Abstract
Prostacyclins are a high-risk category of continuous intravenous infusions increasingly used in hospitals to treat advanced pulmonary arterial hypertension, a rare condition characterized by vasoconstriction and vascular proliferation of the pulmonary arteries. Prostacyclins are given in doses of nanograms per kilogram per minute and have a narrow therapeutic dosing range for each patient. Sudden increases or decreases in dose can be life threatening. Previous studies revealed errors in the administration of these high-risk infusions, which in some instances led to serious adverse events, including death. The literature was reviewed for safety measures in administration of high-risk intravenous medications and input was obtained from leading experts in pulmonary arterial hypertension to create a set of safety recommendations for infusion of prostacyclins.
Original language | English (US) |
---|---|
Pages (from-to) | 32-39 |
Number of pages | 8 |
Journal | Critical care nurse |
Volume | 33 |
Issue number | 5 |
DOIs | |
State | Published - 2013 |
ASJC Scopus subject areas
- Critical Care